Annotated Medicine and Device Lists
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 18.5.2 Oral hypoglycaemic agents |
This medicine has the best evidence for effectiveness and safety. |
| Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health. | Endocrine Oral Hypoglycemic | No observations |
| Costa Rica. Caja Costarricense de Seguro Social. 2019 | 39. Hipoglucemiantes e hiperglucemiantes | No observations |
| Guyana. Essential Medicines List. 2020-2021 | Insulins and Other Antidiabetic Medicines | No observations |
| Haiti. National List of Essential Medicines | 18.04 Antidiabetics and other drugs used in diabetes |
Others observations: For use in patients over 60 as a replacement for glibenclamide |
| Barbados. Barbados National Drug Formulary (BNDF) | 68.20.20 Sulphonylureas | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 18.5.2 Oral hypoglycaemic agents |
This medicine has the best evidence for effectiveness and safety. |
| Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health. | Endocrine Oral Hypoglycemic | No observations |
| Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 | 05.01 DRUGS USED IN DIABETES | No observations |
| Haiti. National List of Essential Medicines | 18.04 Antidiabetics and other drugs used in diabetes |
Others observations: For use in patients over 60 as a replacement for glibenclamide |
| Barbados. Barbados National Drug Formulary (BNDF) | 68.20.20 Sulphonylureas | No observations |
| Bahamas. Drug Formulary | 08.03. Insulin and Oral Antidiabetic Agents | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 18.5.2 Oral hypoglycaemic agents |
This medicine has the best evidence for effectiveness and safety. |
| Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 | 05.01 DRUGS USED IN DIABETES | No observations |
| Haiti. National List of Essential Medicines | 18.04 Antidiabetics and other drugs used in diabetes |
Others observations: For use in patients over 60 as a replacement for glibenclamide |
| Bahamas. Drug Formulary | 08.03. Insulin and Oral Antidiabetic Agents | No observations |
| List | Section | Observation |
|---|---|---|
| Brasil. Relação Nacional de Medicamentos Essenciais. 2020 | A. APARELHO DIGESTIVO E METABOLISMO | No observations |
| Cayman Islands Health Services Authority Pharmacy Drug Formulary | 06.01.02.01 Sulfonylureas | No observations |
| List | Section | Observation |
|---|---|---|
| Brasil. Relação Nacional de Medicamentos Essenciais. 2020 | A. APARELHO DIGESTIVO E METABOLISMO | No observations |
| Guyana. Essential Medicines List. 2020-2021 | Insulins and Other Antidiabetic Medicines | No observations |
| Organisation of Eastern Caribbean States. Medical Products List. 2019-2021 | 8:20 Antidiabetic agents | No observations |
| List | Section | Observation |
|---|---|---|
| Brasil. Relação Nacional de Medicamentos Essenciais. 2020 | A. APARELHO DIGESTIVO E METABOLISMO | No observations |
| Organisation of Eastern Caribbean States. Medical Products List. 2019-2021 | 8:20 Antidiabetic agents | No observations |